Good Health & Medical News — new treatments, disease eliminations, and care reaching people who lacked it, gathered from small independent outlets on every continent, translated into English where needed and ranked by how much each story actually helps. The last three months; the live feed has everything.
Updated 2026-09-07 20:33 UTC · refreshed hourly · open the full live feed →
Baby Macs is thriving after doctors fitted him with a Berlin Heart, a specialized device that takes over pumping for his failing heart. The treatment has stabilized him while he waits for a transplant, turning a likely crisis into a hopeful recovery story.
The World Health Organization has validated Bhutan for eliminating dog-transmitted human rabies, making it the first country in South-East Asia to reach this milestone. Bhutan has recorded no human deaths from dog-mediated rabies since June 2023 and now has the capacity to keep transmission from returning.
Researchers are highlighting how mRNA technology is being used to develop a new generation of cancer vaccines. The approach is being presented as a major step forward in cancer treatment research, with the potential to open new paths for prevention and therapy.
An international clinical trial is testing an experimental Alzheimer’s drug in people who do not yet have memory loss, with the goal of stopping the disease before dementia symptoms appear. If successful, the approach could meaningfully delay or prevent Alzheimer’s for people at high risk.
New trial data show that adding evolocumab to standard cholesterol-lowering treatment reduced the risk of heart attack and stroke in high-risk patients, while also lowering overall mortality. The findings suggest the drug can meaningfully improve survival for people who have not yet had a cardiovascular event.
A collaboration in India has completed 1,000 pediatric stem cell transplants for children with thalassemia. The milestone represents life-changing treatment for patients who can now look toward a healthier future without constant transfusions.
A phase 3 trial found that the experimental pill AD109 reduced breathing interruptions in people with obstructive sleep apnea by about 44%, compared with 18% in the placebo group. It also improved oxygen levels and reduced disease severity, offering a promising option for patients who cannot tolerate standard CPAP therapy.
A genetically modified pig kidney kept Tim Andrews alive for 271 days and allowed him to avoid dialysis during that time. Doctors said the result set a record and represents an important step for transplant medicine.
A patient with end-stage kidney disease lived for 271 days without dialysis after receiving a genetically edited pig kidney, setting a new record for porcine xenotransplantation in a living human. The case also became the first documented bridge from a pig kidney to a later human kidney transplant.
JIPMER facilitated a multi-organ donation that saved four lives. The donated organs also gave other patients a chance at recovery, making this a powerful example of medical generosity and lifesaving care.
The outbreak response has expanded treatment facilities, added many laboratories, and cut test turnaround from over a week to hours. Transmission indicators have fallen, vaccination has begun, and safe burials are now happening much faster, showing the response is changing the outbreak’s trajectory.
The World Health Organization has declared Uganda Ebola-free after 42 days with no new cases. That milestone signals the outbreak has been contained and offers relief to families and health workers across the country.
A visiting US cardiac team worked with Libyan doctors at Tripoli University Hospital to perform 16 successful open-heart surgeries and paediatric cardiac catheterizations over ten days. The effort is part of a programme to build local capacity so more children can receive advanced heart treatment inside Libya.
Scientists developed light-activated drugs that restored light perception and visually guided behavior in blind mice. Two of the most promising compounds worked as eye drops, pointing to a potentially simple future treatment for some forms of blindness.
Researchers are drawing inspiration from a “resurrecting” plant to develop fridge-free vaccines. If successful, the approach could reduce millions of wasted doses and make vaccination easier in places with limited cold storage.
Doctors in Italy performed the world’s first transplant of a central retina, allowing a woman who had been blind for years to regain vision. The case is a major medical milestone and a deeply life-changing result for the patient.
A personalized mRNA vaccine given with Keytruda helped high-risk melanoma patients stay cancer-free longer than patients who got Keytruda alone. The result points to a major step forward in preventing this cancer from returning after surgery.
Researchers at Harvard Medical School found a gene whose blocking helps turn pancreatic cells into cells capable of producing insulin. The finding could lay the groundwork for a new approach to treating diabetes.
Doctors in Almaty performed a complex operation on a newborn baby and removed a tumor weighing two kilograms. The surgery lasted more than two hours and ended successfully, making this a clear medical recovery story.
Researchers have identified a protein target that, when blocked, prevented tumor formation in preclinical models and made cancer cells more vulnerable to radiation. The finding could open a new path toward treating glioblastoma, though human testing is still needed.
A Kentucky mother of three is regaining her mobility after cancerous tumors and spinal surgery left her unable to walk. With help from a Zero-G rehabilitation system, she is now walking, side-stepping, and even throwing a ball while supported by the device.
Two New Zealand psychiatrists have been granted permission to prescribe pharmaceutical-grade MDMA as part of controlled therapy for patients with severe PTSD. It marks a major step for a treatment that can help people who have not improved with standard care.
No new Ebola infections have been recorded in the outbreak epicenter in the Democratic Republic of Congo. The situation is not over, but the latest data points to real progress in containing the virus.
A patient lived with a genetically modified pig kidney for a record nine months, a notable milestone for transplant medicine. The case shows how xenotransplantation is progressing toward providing a bridge for people who need organs.
Duke researchers developed an injectable scaffold that helped stroke-damaged brains grow new blood vessels, support nerve regrowth, and recover movement in mice. By eight weeks, the treated mice performed as well as healthy controls on a movement test, suggesting the approach could one day support stroke recovery.
Dongsan Hospital in Daegu successfully completed a triple-vessel coronary artery bypass without opening the chest bone. The procedure offers a less invasive option for patients who need major heart surgery.
A patient was able to avoid dialysis for nine months after receiving a pig kidney, then later received a human kidney. The case is a notable step forward for transplant medicine and offers hope for people with kidney failure.
Transplant oncology is changing how some liver cancers are treated by using transplantation to remove tumors and restore healthy liver function in carefully selected patients. The approach offers a real chance at better survival for people who qualify, making it a meaningful medical advance.
A once-nightly pill cut breathing interruptions by about 44% in a major phase 3 sleep apnea trial while also improving oxygen levels and disease severity. The result could give patients a simpler alternative to devices like CPAP if it reaches the clinic.
A CAR T-cell cancer therapy dramatically reduced disease activity in six people with severe rheumatoid arthritis that had not responded to other treatments. Three patients reached medication-free remission during follow-up.
Uganda has declared the end of its Ebola outbreak caused by the Bundibugyo virus strain, after 42 consecutive days without a new confirmed case, the World Health Organization and Africa CDC announced. The declaration means the deadly outbreak has been successfully contained nationwide.
Scientists created smart nanoparticles that can both highlight hidden glioblastoma cells during surgery and destroy microscopic cancer left behind afterward. In mice, the approach prevented recurrence and kept all treated animals alive through 60 days, suggesting a promising new direction for brain-cancer treatment.
The FDA has approved a promising new drug for pancreatic cancer, offering a meaningful advance against one of the deadliest cancers. If it performs as hoped, it could improve outcomes for patients who currently have very limited treatment options.
The United States has approved the first drug that targets the root cause of narcolepsy instead of only managing symptoms. That approval could significantly improve life for people living with the disorder.
The article highlights Graeme Clark’s work in overcoming skepticism and funding hurdles to develop cochlear implants. His contribution has transformed life for deaf people by restoring access to sound and communication.
The Tanzania Petroleum Development Corporation is organizing a marathon to raise more than Sh200 million for heart surgeries for 100 children at the Jakaya Kikwete Cardiac Institute. The event is set for November 21 in Dar es Salaam and is being framed as a fundraising effort to give seriously ill children life-saving treatment.
María Consuelo Córdoba canceled her euthanasia request after receiving commitments for two surgeries through medical and private-sector support. The outcome gives her a new path forward with treatment and financial backing.
A trial in Nairobi found that group interpersonal psychotherapy reduced depressive symptoms in pregnant and parenting adolescents much more than standard care. The program can be delivered by trained non-specialists in primary healthcare settings, which makes it a practical way to expand mental health support.
The Council of Ewe Associations of North America has announced plans to establish a cancer research and treatment centre in Ho with the University of Health and Allied Sciences. If completed, the centre would expand research capacity and improve access to specialized cancer care in the Volta Region.
Ghana has expanded its Free Primary Healthcare programme to 135 districts across all 16 regions. The rollout aims to reach 150 districts by the end of 2026 and cover the whole country by the end of 2027.